Changing the practice of medicine: an interview with Mark Fishman

Mark Fishman has served as President of the Novartis Institutes for BioMedical Research (NIBR) since 2002, and in a former academic role was among the first to develop the zebrafish system for studying development and disease. Here, he recalls what it was like to ride the first real wave of zebrafish research, discusses industry-academia collaborations and provides a current perspective on drug development.